Assoc Prof Ravindran Kanesvaran on how new cancer drug list impacts treatment plans
3 Views
administrator
06/28/23
Measures are in place to continue supporting cancer patients, especially for those being treated with drugs not on a new cancer drug list. Associate Professor Ravindran Kanesvaran, chairperson of the Cancer Treatment Fund Committee, shared more on how the list impacts cancer treatment.
Subscribe to our channel here: https://cna.asia/youtubesub
Subscribe to our news service on Telegram: https://cna.asia/telegram
Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia
-
Category
Show more
Facebook Comments
No comments found